FivePhusion has a multi-disciplinary research team under the stewardship of Professors Phil Clingan and Paul De Souza, prominent Australian oncologists, together with a distinguished medicinal chemist, Emeritus Professor John Bremner and Professor Marie Ranson, a notable cell biologist from the University of Wollongong. Its clinical trial is being undertaken at the Southern Medical Day Care Centre in Wollongong and at the Liverpool Hospital in Sydney, Australia.
|Professor Phil Clingan graduated from the University of NSW in 1978 and is a Fellow of the Royal Australian College of Physicians.|
|Margaret Clingan is a Director of FivepHusion. She owns and runs Southern Medical Day Care Centre (SMDCC), a private hospital that specialises in clinical trials for all cancer types that has been operating since 1998. SMDCC has been involved in over 40 international clinical trials. Some of these trials are now the standard treatment regimens for several cancer types. As patron of the Illawarra Cancer Carers, Margaret has helped to raise over $2 million dollars for the local public hospital.|
| Marie Ranson Academic Qualifications: BSc (Hons, Biochemistry) UNSW, 1984; PhD, University of Sydney, 1990. Career Summary: Prof Ranson was appointed as a tenured Teaching and Research Academic at University of Wollongong in 1999, and was promoted to Professor in 2015. During this time she has held appointments as the Cancer Scientific Director at the Illawarra Health and Medical Research Institute, UoW (2009 – 12), acting Head of School of Biological Sciences (2006) and held a Cancer Institute Career Development Fellowship (2005 – 2008). Prior to that, she held a prestigious Fogarty post-doctoral fellowship at the National Institutes of Health, Bethesda MD, USA. Read more.|
|John Bremner was Professor of Organic Chemistry in the Department of Chemistry, University of Wollongong from 1991-2007, and is currently an Emeritus Professor of the University. His research interests cover medicinal chemistry (particularly new anti-bacterial and anti-cancer agents), heterocyclic chemistry, and natural products. In 2001 he received the Adrien Albert Award of the RACI’s Division of Biomolecular Chemistry for his contributions to medicinal chemistry, and received the Halpern Medal (School of Chemistry, Wollongong) in 2008. He is a Fellow of The Royal Australian Chemical Institute (Distinguished Fellowship Award 2011) and a Fellow of The Royal Society of Chemistry.|
|David Ranson is Chairman of Fivephusion Pty Ltd, and has been a director of several proprietary companies over the past 28 years. Since graduating in 1986 BE (Hons 1) UNSW, David has worked in product development in both Australia and the USA.|